Form 4: Assertio Holdings Director David Stark Reports Stock and Option Transactions
SEC Form 4 Filing
Director David Matthew Stark reports acquisition and disposal of Assertio Holdings common stock and stock options.
Summary
- On May 7, 2025, Director David Matthew Stark acquired 53,750 shares of Assertio Holdings common stock and disposed of 53,750 shares.
- Following the transaction, Stark directly owns 107,500 shares of common stock.
- Stark also acquired 81,225 stock options with an exercise price of $0.6171, exercisable from May 7, 2025, to May 7, 2035.
- These transactions were related to restricted stock units and stock options granted in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy at the 2025 Annual Meeting of Stockholders.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects standard compensation practices and insider transactions. There is no indication of positive or negative implications for the company's performance.
Positives
- The grant of stock options and restricted stock units to a director aligns their interests with those of the shareholders.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Comparison to Industry Standards
- Director compensation packages including stock options and restricted stock units are standard practice across the pharmaceutical industry to incentivize performance and align director interests with shareholder value.
- Comparable companies such as Pacira BioSciences and Collegium Pharmaceutical also utilize similar equity-based compensation strategies for their directors.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding director's holdings and incentives.
- The equity-based compensation structure aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/07/2025 | Date of transaction: acquisition and disposal of common stock and grant of stock options. |
| 05/09/2025 | Date of report filing. |
| 05/07/2035 | Expiration date of stock options. |
Keywords
Form 4, beneficial ownership, stock options, common stock, Assertio Holdings, director, David Stark, ASRT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.